Comparative studies of metabolism of simultaneously administered chenodeoxycholic acid and ursodeoxycholic acid in hamsters.
We present the comparative studies of metabolism of chenodeoxycholic acid and ursodeoxycholic acid and their taurine conjugates in the liver and fecal culture from hamsters. When [24-14C]chenodeoxycholic acid and [11,12-3H]ursodeoxycholic acid were simultaneously instilled into the jujunal loop of bile fistula hamsters, both bile acids administered were recovered mainly as their conjugates with taurine and glycine in the fistula bile. The recovery of chenodeoxycholic acid was slightly but significantly higher than that of ursodeoxycholic acid. Chenodeoxycholic acid was more efficiently conjugated with glycine than ursodeoxycholic acid. The glycine/taurine ratio in the biliary chenodeoxycholic acid was 1.9, and that in ursodeoxycholic acid was 1.6. In addition, as much as 6.2% of ursodeoxycholic acid was excreted as the unconjugated form; on the other hand only 2.4% of unconjugated chenodeoxycholic acid was excreted. When [24-14C]chenodeoxycholyltaurine and [11,12-3H]ursodeoxycholyltaurine were simultaneously administered into the ileum loop of bile fistula hamsters, both bile salts were absorbed and secreted efficiently into the bile at the same rate. These results indicate that slightly lower recovery of ursodeoxycholic acid in the bile could be due to the less effective conjugation of ursodeoxycholic acid than chenodeoxycholic acid in the liver. Deconjugation by fecal culture from a hamster proceeded more rapidly in chenodeoxycholyltaurine than ursodeoxycholyltaurine. 7-Dehyroxylation to form lithocholic acid by fecal culture was also faster in chenodeoxycholic acid than ursodeoxycholic acid. The formation of 7-oxolithocholic acid from ursodeoxycholic acid was lesser than from chenodeoxycholic acid. In summary, bacterial deconjugation followed by 7-dehydroxylation to form lithocholic acid seems to be achieved more efficiently with chenodeoxycholic acid than ursodeoxycholic acid.
Department of Pharmaceutical Services, Hiroshima University Hospital, Japan.
K
K
Kihira
T
T
Yamauchi
T
T
Kuramoto
M
M
Une
M
M
Yoshii
T
T
Hoshita
D000818:Animals; D001646:Bile / Q000378:metabolism*; D001711:Biotransformation; D002250:Carbon Radioisotopes; D002635:Chenodeoxycholic Acid / Q000008:administration & dosage / Q000378:metabolism*; D006224:Cricetinae; D005243:Feces / Q000382:microbiology; D005998:Glycine / Q000737:chemistry; D007413:Intestinal Mucosa / Q000378:metabolism; D007422:Intestines / Q000382:microbiology; D008099:Liver / Q000378:metabolism*; D008297:Male; D008647:Mesocricetus; D013654:Taurine / Q000737:chemistry; D013997:Time Factors; D014316:Tritium; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage / Q000378:metabolism*
D002250:Carbon Radioisotopes; D002635:Chenodeoxycholic Acid; D014316:Tritium; D013654:Taurine; D014580:Ursodeoxycholic Acid; D005998:Glycine